Product NDC 50419-0171

4 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 50419-0171 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 4 active presentations.
  • Generic family: regorafenib.
  • Primary dosage form: Tablet.
  • Common strength: 40 mg / 1.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: Bayer HealthCare Pharmaceuticals Inc..
  • Dosage forms shown: Tablet.
  • Package quantities: 1 Bottle, Plastic, 210 Bottle, 3 Bottle, Plastic, and 4 Bottle, Plastic.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
regorafenib 40 mg / 1 Tablet 1 Bottle, Plastic (Stivarga)50419-0171-0440 mg / 1Tablet1 Bottle, Plastic
regorafenib 40 mg / 1 Tablet 210 Bottle (Stivarga)50419-0171-0040 mg / 1Tablet210 Bottle
regorafenib 40 mg / 1 Tablet 3 Bottle, Plastic (Stivarga)50419-0171-0340 mg / 1Tablet3 Bottle, Plastic
regorafenib 40 mg / 1 Tablet 4 Bottle, Plastic (Stivarga)50419-0171-0640 mg / 1Tablet4 Bottle, Plastic

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.